In the group of patients diagnosed with NSCLC, the change in TIMP1, MMP2 and MMP9 expression was analyzed at three time points of the therapeutic process: before surgery, 100 days after surgery and one year after surgery. The gene discussed is MMP2; the disease is non-small cell lung carcinoma.